secwatch.observer — SEC 8-K summary
======================================

Issuer:     TITAN PHARMACEUTICALS INC (—)
CIK:        0000910267
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001829126-24-007372
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Titan Pharmaceuticals appoints director Brynner Chiam as acting CEO and CFO
---------------------------------------------------------------------------

- Brynner Chiam appointed acting principal executive officer and principal financial officer effective November 6, 2024.
- Company has launched a search for a full-time CEO; Chiam receives no additional compensation.
- Chiam is Tax Director at Black Chamber Management with over 20 years of tax consulting experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/0001829126-24-007372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/titanpharma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-24-007372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer